Gelclair® is the company's third commercialized prescription product
Oral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous membranes, has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force
Severe mucositis/pharyngitis occurred in 70% of head and neck cancer patients in third-party study
Read More
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ADHD and schizophrenia, with 1-2 additional IND applications filed in 2025
Read MoreCLMBR is being featured in Chuze Fitness's Fit Lab, its premium smaller group training concept located inside Chuze Fitness locations
Chuze Fitness is expected to install multiple CLMBRs in each of four locations during the fourth quarter and there is potential for installations in 60 locations
Chuze Fitness is growing quickly, having increased its locations from 44 to 60 in the past two years
